Trinity has been working on key European challenges for over 25 years. We have completed 1,200 European projects in the last five years.

Home / Europe (for approval)

Trinity has been working on European challenges since the inception of our firm. We understand the European market and can offer strategic support to both our global and regional European clients. Our European offices are in London and Munich.

From Strategy to Execution: Our Team Provides Comprehensive Support to Clients Facing Commercialization Challenges in Europe and Beyond

We work closely with other specialized teams to ensure that our clients receive the best possible expertise and solutions.

  • Questions We Can Help You Answer

    What are the key commercial and go-to-market considerations for Europe?

    • How do we sequence launch in the EU? Are there any markets we should not target at all?
    • How do we prepare for launch in each country?
      • How much time is needed and which resources?
    • What is the CHMP evaluation process and how can we optimize the EC approval to launch process?
    • What are some of the key access considerations in each European market?
    • What are the generic adoption levels and how do they vary by country?

    How do we enter and be successful in the European markets?

    • What are some of the business development and outlicensing considerations?
    • What drivers and barriers can we uncover for each market specifically?
    • How can identify and fulfill key unmet needs

    What local innovation and business development opportunities should we pursue?

    • What specific healthcare trends shape the market in each country and how can we explore them?
    • How do stakeholders (physicians, payers, patients) perceive these innovations/developments)?
  • Unique regional capabilities

    France Flag  German Flag  Italy Flag  Spain Flag  Portugal Flag

    • Multilingual experts that are fluent in local languages (French, German, Italian, Spanish, Portuguese, etc.) to ensure optimal execution of research programs
    • Local offices in Munich and London
    • Extensive network of stakeholder types, including KOLs, providers, regulatory experts, payers and patients
    • Ability to conduct market research in different formats (in-person, telephone, video platform, central facility, web survey)

Latest Intelligence About Europe

Meet Our Experts On Europe